$107 Million is the total value of Summit Rock Advisors, LP's 5 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 200.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ACWI | Buy | ISHARES TRmsci acwi etf | $70,603,000 | +42.4% | 957,719 | +20.9% | 65.77% | +18.1% |
HYG | New | ISHARES TRiboxx hi yd etf | $14,773,000 | – | 180,999 | +100.0% | 13.76% | – |
VOO | New | VANGUARD INDEX FDS | $11,212,000 | – | 39,558 | +100.0% | 10.44% | – |
ICVT | New | ISHARES TRconv bd etf | $9,610,000 | – | 135,431 | +100.0% | 8.95% | – |
PHAT | New | PHATHOM PHARMACEUTICALS INC | $1,144,000 | – | 34,776 | +100.0% | 1.07% | – |
IEMG | Exit | ISHARES INCcore msci emkt | $0 | – | -393,289 | -100.0% | -17.88% | – |
IUSV | Exit | ISHARES TRcore s&p us vlu | $0 | – | -509,549 | -100.0% | -26.44% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-10
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ISHARES TR | 29 | Q3 2020 | 90.6% |
ISHARES TR | 26 | Q4 2020 | 51.7% |
ISHARES INC | 11 | Q1 2020 | 64.0% |
ISHARES TR | 11 | Q4 2021 | 47.6% |
ISHARES TR | 9 | Q2 2015 | 34.5% |
PHATHOM PHARMACEUTICALS INC | 9 | Q2 2022 | 1.1% |
ISHARES TR RUS 2000 VAL ETF | 7 | Q4 2022 | 47.0% |
SELECT SECTOR SPDR TR ENERGY | 6 | Q3 2023 | 67.4% |
VANGUARD INTL EQUITY INDEX F | 5 | Q3 2022 | 45.3% |
VANGUARD INDEX FDS | 4 | Q4 2021 | 36.4% |
View Summit Rock Advisors, LP's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-01-26 |
13F-HR | 2023-10-24 |
13F-HR | 2023-07-21 |
13F-HR | 2023-05-09 |
13F-HR | 2023-01-12 |
13F-HR | 2022-11-02 |
13F-HR | 2022-08-01 |
13F-HR | 2022-05-06 |
13F-HR | 2022-02-14 |
13F-HR | 2021-10-26 |
View Summit Rock Advisors, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.